A-867,744
A-867,744
A-867,744 is a chemical compound that acts as a selective antagonist of the cannabinoid receptor type 1 (CB1). It is primarily used in scientific research to study the role of CB1 receptors in various physiological processes.
Chemical Structure and Properties[edit | edit source]
A-867,744 is a synthetic compound with the chemical formula C23H21ClN4O2. It is characterized by its high affinity for the CB1 receptor, which is predominantly found in the central nervous system. The compound is often used in laboratory settings to block the action of endogenous cannabinoids, such as anandamide and 2-arachidonoylglycerol, which naturally bind to CB1 receptors.
Mechanism of Action[edit | edit source]
As a CB1 receptor antagonist, A-867,744 binds to the receptor without activating it, thereby preventing other compounds from binding and activating the receptor. This action makes it a valuable tool for researchers studying the endocannabinoid system, as it allows them to observe the effects of CB1 receptor inhibition in isolation.
Research Applications[edit | edit source]
A-867,744 is used in various research applications, including:
- Neuroscience: To study the role of CB1 receptors in modulating neurotransmitter release and synaptic plasticity.
- Metabolic Studies: To investigate the involvement of CB1 receptors in energy balance, appetite regulation, and obesity.
- Pain Management: To explore the potential of CB1 receptor antagonists in treating chronic pain conditions.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of A-867,744 includes its absorption, distribution, metabolism, and excretion. It is typically administered in vitro or in animal models to assess its effects on CB1 receptor activity. The compound's half-life, bioavailability, and metabolic pathways are subjects of ongoing research.
Safety and Toxicology[edit | edit source]
As with many research chemicals, the safety and toxicological profile of A-867,744 is not fully established. It is used under controlled laboratory conditions, and researchers must adhere to safety guidelines to minimize potential risks.
Also see[edit | edit source]
- Cannabinoid receptor type 1
- Endocannabinoid system
- CB1 receptor antagonists
- Anandamide
- 2-arachidonoylglycerol
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
